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Background:  
Age-specific incidence of the 2009 pandemic influenza 
provides the scientific basis of public health policies and 
the basic science research on the age-related susceptibility 
to influenza. While previous epidemiological studies 
provided vital information for public health policies, most 
did not incorporate age-specific data of asymptomatic, 
symptomatic and severe infection in the analysis. In this 
study, we incorporated data from seroprevalence and 
microbiologically-confirmed infection to estimate the 
relative impact of the pandemic influenza on various age 
groups. 
 
Methods:  
For the determination of pre-pandemic and post-pandemic 
seroprevalence, archived serum samples randomly 
collected at the clinical biochemistry department of Queen 
Mary Hospital in the years 2007 and 2010 were used 
respectively. Microbiologically-confirmed cases and severe 
cases reported to the Centre for Health Protection (CHP) 
from May 1, 2009 to May 23, 2010 were included in our 
analysis. This study was approved by the institutional 
review board of the Hospital Authority of Hong Kong. 
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Results:  
795 and 1000 serum samples were collected in 2007 and 2010 respectively. 
In 2007, 8.7% and 14.2% of individuals had HI titers ≥40 and ≥10 
respectively. The pre-existing cross-reactive antibodies were mainly found 
in patients aged >70 years old. In 2010, the overall proportion of 
individuals with HI titers ≥40 and ≥10 is 23.2% and 42.2%. The highest 
overall microbiologically-confirmed incidence rate was found in the 0-10 
year age group, and decreased with increasing age (ρ=-1.0, p<0.01). A total 
of 282 severe cases were reported with a mean age was 47.6 years. The 
incidence rate of severe cases showed an apparent bimodal age distribution, 
with higher incidence rate in the age group 0-10 and those older than 50 
years old, and the highest incidence rate being those between 51 and 60 
years old. 
 
Figure 2. Microbiologically confirmed 
incidence rate 
Conclusion:  
While the young adults were 
most commonly affected, the 
clinical consequence is most 
alarming in children and 
older adults aged over 50 
years. Public policies should 
continue to target this high 
risk group. 
Figure 1. Prevalence of seropositive individuals  
a) hemagglutination inhibition titer ≥40 
Figure 1. Prevalence of seropositive individuals  
b)  hemagglutination inhibition titer ≥10 
